66
Participants
Start Date
July 9, 2019
Primary Completion Date
May 15, 2022
Study Completion Date
May 15, 2022
Acalabrutinib
"Acalabrutinib, lenalidomide, rituximab will be given as described in the Arms decriptions. Day 1 to day 28 is considered one cycle, and cycles will be repeated every 4-weeks, for 6 cycles.~After 6 cycles, maintenance of acalabrutinib 100mg bid will be administered up to 1 year for subjects whose best responses- to the regimen are partial response or complete remission."
Seoul National University Hospital, Seoul
Seoul National University Hospital
OTHER